Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of ATL-962 in Obese Diabetics

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Type II diabetes~* Body mass index 28-45kg/m2~* HbA1c 6%-10%~Exclusion Criteria:~* Significant weight loss in the previous 3 months~* Weight gain during the run-in period~* Other serious systemic conditions, except controlled hypertension, mild asthma, and primary hypothyroidism~* History of GI disorders~* Previous surgery for weight loss

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).